Clinical Trials Directory

Trials / Completed

CompletedNCT01129050

Effects of Omega-3 Fatty Acids on Markers of Inflammation

Effects of Plant and Marine Omega-3 (w-3) Fatty Acids on Inflammatory Markers In Insulin Resistant Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
102 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The major purpose of this study is to examine the effect of two sources of dietary omega-3 fatty acids, each given at two doses, on potential health benefits related to cardiovascular disease prevention. The two sources of dietary omega-3 fatty acids will be fish oil, and flaxseed oil.

Detailed description

The primary aim of this study is to examine the effect of two sources of dietary omega-3 fatty acids, each given at two doses, on potential health benefits related to cardiovascular disease prevention. The two sources of dietary omega-3 fatty acids will be fish oil, and flaxseed oil. Each will be given at a lower dose that could realistically be achieved from food sources alone, and at a higher dose that could not realistically be achieved from food alone and would require supplementation. The outcomes being studied are markers of inflammation. The subjects being studied are those with elevated risk factors for diabetes and heart disease that meet the criteria for the "metabolic syndrome". These are the people who are currently not diabetic, and who have not been diagnosed yet with heart disease, who are at risk of developing these diseases and who would likely benefit the most from the omega-3 therapy should it prove to be effective.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFish OilFish oil capsule
DIETARY_SUPPLEMENTFlaxseed OilFlaxseed oil capsule
DIETARY_SUPPLEMENTPlaceboSoybean oil capsule

Timeline

Start date
2007-04-01
Primary completion
2008-12-01
Completion
2008-12-01
First posted
2010-05-24
Last updated
2023-02-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01129050. Inclusion in this directory is not an endorsement.